Announcements

RB Press release - 01/05/2012
Q1 On Track - 2012 Full Year Targets Reiterated

Results at a Glance	Q1 £m	% change actual exchange	% change constant exchange
Net Revenue	2,357	+3%	+4%
- Like-for-like Growth (ex RBP) *	+4%
Net Revenue by Segment
- ENA	1,168	-2%	-1%
- LAPAC	580	+13%	+13%
- RUMEA	369	+5%	+9%
- Food	73	+7%	+6%
Total ex RBP	2,190	+3%	+4%
- RB Pharmaceuticals	167	+7%	+6%
Total Net Revenue	2,357	+3%	+4%
Net Revenue by Category
- Health	461	+0%	+0%
- Hygiene	964	+5%	+7%
- Home	486	+1%	+2%
- Potfolio Brands	206	+0%	+2%

* Like-for-like (“LFL”) growth excludes the impact of changes in exchange rates, acquisitions, disposals and discontinued operations.


Highlights:

• Like-for-like net revenue growth excluding RBP of 4%, well ahead of our market growth
• Strong growth in emerging market areas
• Satisfactory performance in ENA in challenging market conditions
• Growth driven by Dettol / Lysol, Harpic, Finish, and Durex
• RBP – volume (mg) market share of Film grown to 53%

Commenting on these results, Rakesh Kapoor, Chief Executive Officer, said:

“Reckitt Benckiser’s first quarter results were on track and in line with our ingoing expectations. High quality, volume led LFL growth of 4% was driven by continued excellent performance in Emerging Market Areas and the success of innovations like Veet Easy Wax Roll-On and the Lysol No-Touch Kitchen System. RBP continues to make very good progress with the patient preferred Suboxone sublingual film now at 53% market volume share, up from 48% at the end of 2011.

These results give us the confidence to reiterate our FY 2012 target of like-for-like net revenue growth* of 200bp above our market growth rate of 1-2%. We also expect to maintain full year operating margins.*”

*ex RBP

 To view the full press release please click on the link below